Roche Wins FDA Authorization On High-Volume Monkeypox Test

The test, which is the first for the condition to win an EUA using actual patient samples, provides results in about three and a half hours. 

Monkeypox Test Tube
• Source: Shutterstock

A high-volume automated monkeypox diagnostic from Roche Diagnostics Corp. has been granted an Emergency Use Authorization by the US Food and Drugs Administration, the company announced recently. The cobas MPXV is the first test for the disease to be authorized based on clinical trials that used actual patient samples.

The cobas MPXV, which can be used with Roche’s cobas 6800/8000 systems, is a real-time polymerase chain reaction (PCR) test...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Approvals

More from Policy & Regulation

MDUFA VI Launches With Public Meeting, Call For Comments

 
• By 

Preparations for the reauthorization of the Medical Device User Fee Amendments for 2028-2032 are underway, with the US FDA announcing a public meeting for 4 August. After negotiations with industry and other stakeholders, a draft agreement is due to Congress by 15 January 2025.

Permanent FDA Top Lawyer Expected After HHS Counsel Confirmation

 
• By 

Robert Foster, HHS deputy general counsel and chief counsel for food, research and drugs, is temporarily heading the Office of Chief Counsel, but a permanent appointee is expected after Michael Stuart's confirmation as HHS general counsel.

FDA Drops Package Labeling Guidance For Hernia Mesh Manufacturers

 

The US FDA recently published a draft guidance document for manufacturers of mesh products that are used during several types of hernia repair procedures.